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Polybrominated Biphenyls in Model and
Environmentally Contaminated Human
Blood: Protein Binding and
Immunotoxicological Studies
by John Roboz,* John Greaves* and J. George Bekesi*
A review and summary is given of analytical, biochemical, and immunological studies made following
an immunodiagnostic investigation which revealed significant decreases in the numbers, and changes in
the functional integrity, of both T-and B-lymphocytes in a group of Michigan dairy farmers exposed to
polybrominated biphenyls (PBB) which had been inadvertently introduced into the food chain in 1973. A
quantification techniquebasedonselectedionmonitoringofbromineanions, obtainedinnegativechemical
ionization, permitted determination of 10-35 pg of individual PBB congener per mL serum, a 20-fold
improvement over electron capture gas chromatography. An in vitro spiked system was established and
showntobearepresentative model ofenvironmentallycontaminatedblood. Immunoprecipitation followed
bymassspectrometric quantificationdeterminedthatthedistribution ofPBBamongplasma, erythrocytes,
mononucleocytes and polymorphonucleocytes was 89:9:<1:<1. In plasma 80% of the PBB was bound to
apolipoproteins B and A in a 3:1 ratio. No preferential absorption of PBB congeners was found in the
blood compartments suggesting that changes in the relative abundances of PBB congeners observed in
longitudinal studies on Michigan subjects reflect differences in excretion rates or metabolism. A repeat
in 1981 of the immunodiagnostic tests conducted in 1976 revealed a virtually complete persistence of the
immune dysfunctions in the Michigan farmers exposed to PBB a decade ago.
Introduction
In 1973, livestock feed for dairy cattle in Michigan
wascontaminated withpolybrominatedbiphenyls (PBB)
when Firemaster BP-6, an industrialfireretardant, was
mistaken for Nutrimaster, a magnesium oxide cattle
feed supplement. The resulting toxicosis in animals led
to the quarantining of 500 farms and the destroying of
32,000 cattle, 1.6 million chickens, and 5 million eggs.
Acute PBB-related syndromes were reported among
chemical workers directly exposed to PBB and farmers
who commonly consumed their own dairy and meat
products. As a result of the statewide distribution of
dairy produce and meat from the contaminated farms,
the majority of Michigan residents were exposed to
PBB during the 5 years after the contamination.
The recognition of the potentially serious long-term
consequences of this accident prompted extensive ani-
mal and in vitro studies on the hepatotoxic, neurotoxic,
immunotoxic, and carcinogenic properties of PBB, and
the establishment of cohorts of thousands of exposed
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persons to serially monitor blood levels in 1-2 yr inter-
vals. Such studies have been continuing to date, even
though the contamination ended in 1978, and the man-
ufacture of PBB was banned in 1978. A recent review
summarizes the scientific as well as the political aspects
of the PBB contamination in Michigan and provides a
list of relevant references (1). It has been estimated
that 90% ofthe population ofthe State ofMichigan now
carries a body burden of PBB (2). Continued interest
in PBB isjustified by the potential oflong-term and as
yet undetected medical consequences, e.g., decreased
developmental ability of children after neonatal expo-
suretoPBB (3)andofPBBuptakedue totheextremely
slow excretion/metabolism of this class of compounds
(4,5).
Since 1976, the Environmental Sciences Laboratory
andthe Immunotoxicology andAnalyticalBiochemistry
Laboratories ofthe Department ofNeoplastic Diseases
of the Mount Sinai School of Medicine have been
conducting epidemiological, comprehensive clinical and
neurological, immunotoxicological, analytical, and bio-
chemical studies on Michigan farm residents, Michigan
chemical workers, and controls from Wisconsin farms
and NewYorkCity. ThepresentpaperreviewstheworkROBOZ, GREAVES AND BEKESI
done in our laboratories on the analytical chemistry,
protein binding, and immunotoxicological effects of
PBB; also included are results of pilot experiments on
alternative approaches to the study ofprotein binding,
and some longitudinal data on immunoglobulins.
Quantification by Selected Ion
Monitoring
Gas chromatography with electron capture detection
(EC-GC) has been the primary analytical technique for
the quantification of PBB in body fluids and fatty
tissues in body burden studies (6-8). The concentration
of PBB in serum is usually expressed in terms of the
most abundant hexa isomer (2,2',4, 4',5,5'-hexabromo-
biphenyl, HxBB), and the detection limit for HxBB in
serum by EC-GC is approximately 1 ng/mL (1 pbb);
blood levels of this order have been reported in many
Michigan subjects (9).
The possibility that PBB congeners are preferentially
accumulated or excreted has been suggested in studies
in Michigan farmers and chemical workers (10,11) as
well as in experimental animals (12), and attention was
called to the potential importance of several minor
components of Firemaster (13). The positive identifi-
cation and quantification of PBB congeners other than
the most abundant HxBB in the general population
requires analytical techniques which are more specific
and have lower limits of detection than EC-GC.
Apilot studyontheuse ofpositivechemicalionization
mass spectrometry with selected ion monitoring (14)
revealed that a vast improvement in specificity can be
provided when the protonated molecular ions of indi-
vidual PBB are monitored. Detection limits, however,
appeared inadequate for the determination of blood
levels in the general population. A subsequent investi-
gation ofthe mechanism ofhalogen anion formation by
polybrominated compounds in negative chemical ioniza-
tion mass spectrometry revealed *that dissociative
electron capture by polybrominated compounds leads to
the formation of bromine anions in great abundance
(15). This observation led to the development of a
complete analytical methodology for the quantification
of individual PBB in serum by the selected ion
monitoring of bromine anions (m/z = 79) obtained in
negative chemical ionization with nitrogen as the
reagent gass (16). Detection limits were 10 pg/mL for
pentabromobiphenyls and 35 pg/mL for the other PBB
congeners, an approximately 20-fold improvement over
electron capture gas chromatography. Although this
technique is not as specific as the one based upon the
monitoring of protonated molecular ions in positive
chemical ionization or the molecular anions in negative
chemical ionization, specificity is still much higher than
in EC-GC because only bromine yielding compounds,
with GC retention times identical to those of PBB (a
highly unlikely occurrance), may conceivably interfere
(particularly when the m/z = 81 peak is comonitored).
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FIGURE 1. Recovery ofadded 14C-2,2',4,4',5,5'-hexabromobiphenyl
from water and serum under various sample preparation condi-
tions (see text).
Regardless of the analytical technique used for
detection and quantification, the extraction of PBB
from the serum (plasma) samples must be as complete
as possible. Figure 1 shows the recovery of PBB by
extraction (twice) with 5-fold volumes ofhexane-diethyl
ether (1:1, v/v) under various conditions. These experi-
ments were carried out using universally labeled
14C-HxBB (specific activity: 10.2 mCi/mmole). The top
line of Figure 1 shows that 96% recovery can be
achieved from water. The middle line shows that only
17% of HxBB can be recovered from serum with a
straight extraction with hexane-diethyl ether. The
strength ofthe bindingofPBB to serumproteins, which
is sufficient to prevent efficient solvent extraction, can
bereducedsignificantlybyadding2volumesofmethanol
(and vortexing) prior to extraction. It is seen that 93%
recovery is possible when serum is first treated with
methanol to precipitate proteins and the precipitate is
not removed prior to extraction with hexane-diethyl
ether. PBB is still bound to protein after the methanol
treatment but the bonds are apparently weakened to
such a degree that the addition of the solvent mixture
can completely release all PBB present. When the
methanol precipitate is removed by centrifugation prior
to extraction, and the precipitate and supernatant are
extracted separately, the amounts extracted are 72%
and 21%, respectively (Fig. 1). The lipophilic nature of
PBB suggests that the nonprotein-bound fraction is
associated with the free lipids of serum.
Protein Binding
Binding to Individual Serum Proteins
Figure 2 summarizes the results of a series of
experiments where 14C-HxBB (20 ng) was incubated
(37°C, 1 hr) separately with -y -globulin, albumin, and
apolipoprotein B (2-40 mgeach) dissolved in water. It is
seen that even in a noncompetitive situation the PBB is
bound most efficiently by proteins with hydrophobic
components.
In Vitro Models
The protein binding behavior ofPBB in environmen-
tally contaminated blood has been successfully mim-
icked by spiking whole blood as well as plasma/serum
with either 14C-HxBB or individual congeners (incuba-
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FIGURE 2. Percentage of'4C-2,2',4,4',5,5'-hexabromobiphenyl (14C-
HxBB) bound by different concentrations ofindividual serum pro-
teins incubated (37°C, 60 min) in aqueous solution with 20 ng 14C-
HxBB.
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tion: 37°C, 30 min). PBB were detected and quantified
bothby scintillation counting and negative chemical ion-
ization mass spectrometry (17). The left of Figure 3
shows the distribution of PBB when they were incu-
bated with whole blood. The vast majority of the PBB
became associated with plasma (89%); 9% was associ-
ated with erythrocytes and 1% or less with each of the
mononucleocytes and polymorphonucleocytes. If, how-
ever, the amount of PBB per cell is considered, there
is an approximately 100-fold excess ofPBB in the white
cell fractions in comparison with the erythrocyte frac-
tion. Similar conclusions were drawn from experiments
usingpositive chemicalionization mass spectrometry on
blood from exposed Michigan chemical workers (14).
The relatively large amount of PBB associated with
white blood cells is possibly the cause of the immuno-
logical dysfunctions thatresulted from exposure to PBB.
A direct comparison between model plasma and en-
vironmentally contaminated plasma (i.e., plasma from
a Michigan farmer) is shown in the midsection ofFigure
3. The apolipoprotein B and A fractions were obtained
by immunoprecipitation with the appropriate monospe-
cific polyvalent antisera. The HxBB content ofthe sep-
arated fractions of the model plasma was determined
by scintillation counting while the corresponding frac-
tions from the Michigan sample were analyzed by neg-
ative chemical ionization mass spectrometry (17). It is
seen that within experimental error the environmen-
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FIGURE 3. Illustration of several kinds ofexperiments to study the distribution and protein binding ofPBB in blood. The first column shows
the distribution of 14C-2,2',4,4',5,5'-hexabromobiphenyl (14C-HxBB) in whole blood (MC = mononucleocytes, PMN = polymorphonucleo-
cytes, RBC = red blood cells): the second and third columns show a comparison of distribution of'4C-HxBB in model plasma with that of
HxBB in environmentally contaminated plasma (APO-B = apolipoprotein B, APO-A = apolipoprotein A). Selected ion monitoring profiles
(m/z = 79) = distribution of PBB congeners in plasma fractions obtained from an environmentally contaminated blood sample. Penta-1 =
2,2',4,4',5,5'-pentabromobiphenyl; Penta-2 = 2,3',4,4',5-pentabromobiphenyl; Hexa-1 = 2,2',4,4',5,5'-hexabromobiphenyl, Hexa-2 =
2,2',3,4,4',5'-hexabromobiphenyl; Hexa-3 = 2,3',4,4',5,5'-hexabromobiphenyl; Hepta = 2,2',3,4,4',5,5'-heptabromobiphenyl.
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tally contaminated samples were well represented by
the in vitro model. The fact that the amount of HxBB
not precipitated by antiapolipoprotein B could be pre-
cipitated by antiapolipoprotein A confirmed that essen-
tiay all protein-bound HxBB was bound to lipoproteins.
The 3:1 ratio between the amount of PBB-bound apo-
lipoproteins B and A reflect the 3:1 ratio of the lipid
contents ofthese proteins rather than their amino acid
content (1.6:1), and suggests that PBB bindstothelipid
portions oflipoproteins and that the composition ofthe
rest ofthe lipoprotein molecule is ofnoimportance (17).
The availability ofarepresentative model permits the
in vitro study of the behavior of individual PBB
congeners (or mixtures) at any desired absolute (or
relative) concentration, which is ofimportance because
ofthe limited availability ofblood samples from affected
Michigan residents and the very low concentrations of
several PBB congeners in those samples.
Congener Profiles
In a set ofexperiments whole blood was spiked with
equal amounts of HxBB, 2,2',4,5,5'-pentabromobi-
phenyl (a component of Firemaster BP-6 known to be
excreted and/or metabolized) and 2,2',4,5',6-pentabro-
mobiphenyl (not identified in Firemaster BP-6) and the
PBB congeners were quantified by mass spectrometry
in the cell-free, mononuclear, polymorphonuclear, and
erythrocytes fractions. In spite of the huge (up to
200-fold) differences in the amounts of PBB present in
the cell-free fraction with respect to otherfractions, the
relative amounts ofthe congeners, within experimental
error, were the same for each fraction (17).
Mass spectrometric studies on preferential bindingin
environmentally contaminated samples are illustrated
in the right side ofFigure 3, which shows how the PBB
congeners were distributed in the separated apolipo-
proteinB, A, andnonprotein-bound fractions ofaserum
sample from a Michigan subject (18). Qualitatively,
these three profiles are similar and show very little, if
any, selective binding of the congeners. The lack of
selective binding indicates that the changes that have
been observed in the PBB profiles ofMichigan subjects
(10,11,16) are the results of selective metabolism or
excretion rather than selective absorption.
High Performance Liquid
Chromatography (HPLC)
The recent availability ofgel permeation columns for
theseparationofproteins offersanalternative approach
to the study of the protein binding of PBB. Here the
separating power of HPLC is combined with the de-
tection and quantification of PBB in collected fraction
from serum eitherbyscintillation counting (model sam-
ples) or mass spectrometry (model or environmentally
contaminated samples). Toexplorethefeasibilityofthis
approach, 1 mL serum was incubated with 40 ng of"'C-
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FIGURE 4. Chromatographic profile ofa model plasma on a size ex-
clusion HPLC column (Model I-250, Waters Associates). Histo-
gran (dotted area) shows distribution of the C-2,2',4,4',5,5'-
hexabromobiphenyl spike in collected fractions.
HxBB at 37°C for 1 hr. The serum was extracted with
3 mL hexane and the radioactivity ofthe organic phase
determined. The aqueousphase was used forthe HPLC
experiments without any further sample preparation;
250-,uL aliquots were injected directly onto the HPLC.
Figure 4 shows the HPLC profile ofsuch an aliquot on
an I-250 protein column (Waters Associates, Milford,
MA). Phosphate buffer (0.05 M, pH 5.7) was the eluent
(flow rate = 1.0 mL/min) with detection by UV ab-
sorbance at 254 nm. Fractions were collected at 2-min
intervals, and radioactivity was determined in all col-
lected fractions. Radioactivity dataare shownin Figure
4 superimposed on the HPLC proffle. It is seen that
about one-half of the PBB eluted in the first fraction
that contained proteins (fraction 2). Based upon molec-
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FIGURE 5. Comparison ofthe relative numbers and results ofseveral immune function tests ofT-and B-lymphocytes in PBB-exposed Michigan farm residents with Wisconsin farm residents (n =46) taken as 100%: (0) subpopulation ofMichigan subjects with normal T-and B-lymphocyte numbers and function (n=27); (a) subpopulation of Michigan subjects with reduced T-and B-lymphocyte numbers and impaired immune functions (n = 18).
ularweightcalibrations it wasdeterminedthatthisfrac-
tion contained the apolipoprotein B (approximate MW,
3 x 10' daltons). The total radioactivity recovered from
the collected protein fractions accounted for 79% ofthe
total initial spike added. The radioactivity recovered
from the hexane extract was 22%; thus the overall re-
covery was 101%. Improved chromatographic separa-
tion and theidentification ofthe proteins inthe collected
fractions will yield additional information on the nature
of the binding of PBB to serum proteins.
PBB-lnduced Immune Dysfunction:
Discovery in 1976
A variety of tests were used to assess the immune
status of PBB-exposed Michigan dairy farmers in
comparison with control populations of non-exposed
Wisconsin dairy farmers and New York City residents.
The tests included total lymphocyte, and T- and
B-lymphocyte counts, lymphocyte function tests using phytohemoglutinin (PHA), for T cells, concanavalin A
(CONA), T cells, mixed lymphocyte culture (MLC), and
pokeweed mitogen (PWN), for B cells, and determin-
ation ofIgA and IgG levels. Abnormalities found in up
to 40% of the Michigan population included significant
decreases in the numbers of T and B lymphocytes and
increases in "null" cells, and changes in the functional
integrity of both T and B lymphocytes (19).
The numerical values given by Bekesi et al. (19) are
showngraphicallyinFigure 5. The45 Michigan farmers
studied were subdivided into two populations, with 27
individualshavingnormalT-andB-lymphocyte numbers
and functions (dotted columns) and 18 individuals with
significant deviations (p<0.001) from normal values
(cross-hatched columns). The data forthe two Michigan
subpopulations are shownrelative totheWisconsin con-
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FIGURE 6. Persistence of reduced T-lymphocyte numbers and altered phytohemoglutinin response in PBB-exposed Michigan dairy farmers from 1976 to 1981. Shaded areas contain the values of the upper 95% of Wisconsin controls.
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FIGURE 7. Persistence of increased IgG and IgA levels in PBB-
exposed Michigan dairy farmers from 1976 to 1981. Shaded areas
contain the values of the upper 95% of Wisconsin controls.
trol samples (taken as 100%). The total number oflym-
phocytes was apparently normal in all the Michigan
residents, due to the presence of 40% "null" cells (i.e.,
cells having no detectable surface markers). Figure 5
also shows considerable decreases in the response to T-
lymphocyte mitogens (PHA and CONA), and to a T-
lymphocyte proliferation test (MLC) for the 18 affected
Michigan subjects, while in the 27 nonaffected Michigan
subjects the PHA and CONA values were unchanged,
and the MLC values decreased only moderately with
respect to Wisconsin controls. The reduction in the re-
sponse to stimulation (both T-and B-lymphocytes) was
approximately double the amount that would be ex-
pected on the basis of the reduced numbers of cells
present in the immunodeficient individuals. Thus, in ad-
dition to the reduced numbers ofT-and B-lymphocytes,
the functional abilties of the remaining cells were also
compromised. A likely, but not proven, reduction ofthe
number of helper T-cells may also have contributed to
the decrease in B cell functionality.
Among the immunoglobulins, increases of 83% for
IgG and 43% of IgA were observed for Michigan dairy
farmers with respect to Wisconsin controls.
It was concluded that as high as 40% ofthe Michigan
residents studiedhadimpairedimmunefunctionsin 1976.
Persistence of Immune
Dysfunction: Reassessment in 1981
The immune status of40 Michigan farm residents and
41 Wisconsin controls were re-examined in 1981. The
results revealed that 17 of the Michigan subjects still
suffered from an altered immune state. Figure 6 shows
comparison data on the number of T-lymphocytes and
on PHA stimulation obtained in 1976 and in 1981. The
correlationbetween the two sets oftests was high; e.g.,
r=0.87 for the numbers of T-lymphocytes giving a p
value of <0.01. Scatter plots obtained for all the other
cellfunction tests (Fig. 5)indicated asimilarpersistence
of these manifestations of the suppresions of immuno-
competence (20,21).
Increases in IgA and IgG levels encountered in 1976
were also found to be persistent (Fig. 7), with statis-
tically significant correlations between the 1976 and 1981
data.
It is concluded that immune dysfunctions were still
present in 1981, 5 years after initial testing, 8 years
after initial expose to PBB, and 3 years after the Mich-
igan food chain was found to be clear of PBB contami-
nation. These dysfunctions are the results of either a
permanently damaged immune system or to the contin-
uously deleterious affects of PBB available from the
apparently inexhaustible store in the adipose tissues of
the Michigan dairy farmers exposed to PBB a decade
ago.
This work was supported by a contract from the National Institute
of Environmental Health Sciences, No. NO-1-ES-9-0004.
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